Key Insights
- Significant control over Shanghai HeartCare Medical Technology by retail investors implies that the general public has more power to influence management and governance-related decisions
- A total of 7 investors have a majority stake in the company with 52% ownership
- Insider ownership in Shanghai HeartCare Medical Technology is 18%
A look at the shareholders of Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) can tell us which group is most powerful. The group holding the most number of shares in the company, around 30% to be precise, is retail investors. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
Clearly, retail investors benefitted the most after the company’s market cap rose by HK$78m last week.
In the chart below, we zoom in on the different ownership groups of Shanghai HeartCare Medical Technology.
